This paper presents a choice experiment, which values reductions in mortality risk on Alpine roads. These roads are on one hand threatened by common road hazards, on the other hand they are also endangered by natural hazards such as avalanches and rockfalls. Drawing on choice data from...

Today, the global pharmaceutical product value chain is becoming increasingly complex and this has led to the emergence of 'multiple quality standards' for medicines. But this non-uniformity in the quality of medicine is also contingent upon both the regulatory milieu in the country of...

Drug Regulation has been the focus of several recent policy reform efforts in India, starting with the Mashelkar Committee Report in 2003 to the most recent report of the Ranjit Roy Chaudhary Committee in 2013. Nevertheless, the regulatory structure continues to be plagued with several...

Ultra-hazardous risky activities as the nuclear industry cannot be considered as "normal industries" i.e. without abnormal environmental and health risks. This theoretical paper studies the industrial organization of electro nuclear sectors from the view point of the general cost of impact...

In this article, we argue for application of the Human Factors Analysis and Classification System (HFACS) to proactive incidence prevention in the public health system response to COVID-19. HFACS is a framework of causal categories of human errors typically applied for systematic retrospective...

This paper discusses findings from a review of recent literature on support for securing compliance and better practice in occupational safety and health (OSH) in the changing world of work in advanced market economies. It explores innovative responses of regulators and private actors to the...